Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
This study aimed to identify factors that significantly contribute to the chronicity of symptoms in patients with temporomandibular disorders (TMD). Statistical, machine learning, and deep learning models were used for analysis. The study include 239 patients with TMD (161 women and 78 men; mean age 35.60 ± 17.93 years), diagnosed using Diagnostic Criteria for TMD (Axis I). Participants were categorized into: acute TMD (< 6 months) and chronic TMD (≥ 6 months) (51.05%). Significance clinical findings revealed that temporomandibular joint (TMJ) noise and bruxism were more frequently reported in patients with chronic TMD than in those with acute TMD. The visual analog scale (VAS) score, reflecting subjective pain intensity, was significantly higher in chronic TMD than in acute TMD. Additionally, patients with chronic TMD had shorter average sleep durations than their acute counterparts. STOP-Bang total scores were higher in chronic TMD (3.02 ± 2.09 vs. 2.39 ± 1.73, p = 0.012) than in acute TMD. Magnetic resonance imaging revealed structural abnormalities in patients with chronic TMD, with significantly higher rates of anterior disc displacement (ADD), TMJ osteoarthritis, and joint space narrowing. Using logistic regression—a widely recognized machine learning model—the AUROC for predicting chronic TMD was 0.7550 (95% CI]: 0.6550–0.8550). Significant predictors of chronic TMD included TMJ noise, bruxism, VAS score, sleep disturbance, STOP-Bang total score ≥ 5 (high risk of obstructive sleep apnea), ADD, and joint space narrowing. Deep learning (multilayered perceptron) improved prediction performance by 3.99% over logistic regression (79.49% vs. 75.50%, p = 0.3067). These findings may help clinicians prevent symptom chronicity and mitigate the progression to chronic TMD, ultimately improving patient care.
This study aimed to identify factors that significantly contribute to the chronicity of symptoms in patients with temporomandibular disorders (TMD). Statistical, machine learning, and deep learning models were used for analysis. The study include 239 patients with TMD (161 women and 78 men; mean age 35.60 ± 17.93 years), diagnosed using Diagnostic Criteria for TMD (Axis I). Participants were categorized into: acute TMD (< 6 months) and chronic TMD (≥ 6 months) (51.05%). Significance clinical findings revealed that temporomandibular joint (TMJ) noise and bruxism were more frequently reported in patients with chronic TMD than in those with acute TMD. The visual analog scale (VAS) score, reflecting subjective pain intensity, was significantly higher in chronic TMD than in acute TMD. Additionally, patients with chronic TMD had shorter average sleep durations than their acute counterparts. STOP-Bang total scores were higher in chronic TMD (3.02 ± 2.09 vs. 2.39 ± 1.73, p = 0.012) than in acute TMD. Magnetic resonance imaging revealed structural abnormalities in patients with chronic TMD, with significantly higher rates of anterior disc displacement (ADD), TMJ osteoarthritis, and joint space narrowing. Using logistic regression—a widely recognized machine learning model—the AUROC for predicting chronic TMD was 0.7550 (95% CI]: 0.6550–0.8550). Significant predictors of chronic TMD included TMJ noise, bruxism, VAS score, sleep disturbance, STOP-Bang total score ≥ 5 (high risk of obstructive sleep apnea), ADD, and joint space narrowing. Deep learning (multilayered perceptron) improved prediction performance by 3.99% over logistic regression (79.49% vs. 75.50%, p = 0.3067). These findings may help clinicians prevent symptom chronicity and mitigate the progression to chronic TMD, ultimately improving patient care.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.